                         SEQUENCE LISTING

<110>  ONK Therapeutics Limited
 
<120>  MODIFIED IMMUNE EFFECTOR CELLS WITH INCREASED RESISTANCE TO CELL 
       DEATH

<130>  P40540WO

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  RNA
<213>  Homo sapiens

<400>  1
cccaucuuga acauaccag                                                    19


<210>  2
<211>  20
<212>  RNA
<213>  Homo sapiens

<400>  2
aaccggugca cagagggugu                                                   20


<210>  3
<211>  20
<212>  RNA
<213>  Homo sapiens

<400>  3
auuuacaagc uguacauggg                                                   20


<210>  4
<211>  840
<212>  DNA
<213>  Homo sapiens

<400>  4
atggaacaac ggggacagaa cgccccggcc gcttcggggg cccggaaaag gcacggccca       60

ggacccaggg aggcgcgggg agccaggcct gggctccggg tccccaagac ccttgtgctc      120

gttgtcgccg cggtcctgct gttggtctca gctgagtctg ctctgatcac ccaacaagac      180

ctagctcccc agcagagagt ggccccacaa caaaagaggt ccagcccctc agagggattg      240

tgtccacctg gacaccatat ctcagaagac ggtagagatt gcatctcctg caaatatgga      300

caggactata gcactcactg gaatgacctc cttttctgct tgcgctgcac caggtgtgat      360

tcaggtgaag tggagctaag tccctgcacc acgaccagaa acacagtgtg tcagtgcgaa      420

gaaggcacct tccgggaaga agattctcct gagatgtgcc ggaagtgccg cacagggtgt      480

cccagaggga tggtcaaggt cggtgattgt acaccctgga gtgacatcga atgtgtccac      540

aaagaatcag gcatcatcat aggagtcaca gttgcagccg tagtcttgat tgtggctgtg      600

tttgtttgca agtctttact gtggaagaaa atcatctcct tctttcttgc gctgacgtcg      660

actgcgttgc tcttcctgct gttcttcctc acgctccgtt tctctgttgt taaacggggc      720

agaaagaaac tcctgtatat attcaaacaa ccatttatga gaccagtaca aactactcaa      780

gaggaagatg gctgtagctg ccgatttcca gaagaagaag aaggaggatg tgaactgtga      840


